Insufficient scRNA-seq data for expression of MOCS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1719.04 | 180 / 180 | 100% | 23.01 | 429 / 430 |
liver | 100% | 3591.92 | 226 / 226 | 99% | 24.90 | 403 / 406 |
kidney | 100% | 3327.53 | 89 / 89 | 99% | 22.61 | 894 / 901 |
adrenal gland | 100% | 2623.64 | 258 / 258 | 98% | 14.75 | 226 / 230 |
brain | 98% | 1294.34 | 2583 / 2642 | 100% | 22.79 | 703 / 705 |
thymus | 100% | 3541.88 | 652 / 653 | 97% | 14.62 | 587 / 605 |
breast | 100% | 6077.39 | 459 / 459 | 94% | 10.46 | 1047 / 1118 |
skin | 94% | 1582.93 | 1709 / 1809 | 99% | 16.75 | 465 / 472 |
pancreas | 96% | 1237.18 | 314 / 328 | 95% | 9.05 | 169 / 178 |
prostate | 97% | 1578.22 | 238 / 245 | 90% | 7.95 | 452 / 502 |
lung | 100% | 4436.44 | 578 / 578 | 84% | 7.34 | 972 / 1155 |
bladder | 100% | 2148.14 | 21 / 21 | 84% | 11.44 | 424 / 504 |
esophagus | 99% | 1993.77 | 1427 / 1445 | 76% | 5.29 | 139 / 183 |
stomach | 100% | 1735.00 | 358 / 359 | 75% | 6.32 | 214 / 286 |
intestine | 100% | 2250.41 | 965 / 966 | 72% | 5.18 | 381 / 527 |
uterus | 100% | 2419.59 | 170 / 170 | 59% | 7.69 | 269 / 459 |
adipose | 100% | 6858.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4360.66 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 25.11 | 80 / 80 |
muscle | 100% | 3002.18 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.74 | 1 / 1 |
heart | 99% | 2884.32 | 854 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 5.34 | 32 / 45 |
spleen | 61% | 519.49 | 148 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 34% | 2.01 | 10 / 29 |
peripheral blood | 0% | 2.63 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006777 | Biological process | Mo-molybdopterin cofactor biosynthetic process |
GO_1990140 | Cellular component | molybdopterin synthase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_1904047 | Molecular function | S-adenosyl-L-methionine binding |
GO_0005525 | Molecular function | GTP binding |
GO_0061798 | Molecular function | GTP 3',8'-cyclase activity |
GO_0051539 | Molecular function | 4 iron, 4 sulfur cluster binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0061799 | Molecular function | cyclic pyranopterin monophosphate synthase activity |
Gene name | MOCS1 |
Protein name | Molybdenum cofactor synthesis-step 1 protein B splice type I Molybdenum cofactor biosynthesis protein 1 (Cell migration-inducing gene 11 protein) (Molybdenum cofactor synthesis-step 1 protein A-B) [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)] Molybdenum cofactor synthesis-step 1 protein A splice type I Molybdenum cofactor synthesis 1 |
Synonyms | RP1-278E11.2-007 RP1-278E11.2-006 MIG11 |
Description | FUNCTION: Isoform MOCS1A and isoform MOCS1B probably form a complex that catalyzes the conversion of 5'-GTP to cyclic pyranopterin monophosphate (cPMP). MOCS1A catalyzes the cyclization of GTP to (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate and MOCS1B catalyzes the subsequent conversion of (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate to cPMP. . |
Accessions | Q9NZB8 ENST00000340692.10 [Q9NZB8-1] ENST00000373181.8 [Q9NZB8-4] F8WCK1 Q9NP27 ENST00000373195.7 [Q9NZB8-7] ENST00000373188.6 [Q9NZB8-5] Q5TCE5 Q9NP26 Q5TCE4 ENST00000487924.1 |